Doesn’t metoclopramide allow a significant decrease in antacid consumption?
Metoclopramide, by its action on the inferior esophageal sphincter, and on the motility of the lower esophagus, decreases the incidence of gastroesophageal reflux. It is therefore logical to think that this substance may permit reduction in the intake of antacids.
KeywordsPlacebo Cimetidine Metoclopramide
- 2.Bright-Asare P, El Bassoussi M (1980) Cimetidine, Metoclopramide or placebo in the treatment of symptomatic gastroesophageal reflux. J Clin Gastroenterology, 149–156Google Scholar